Skip to main content
    E

    Elanco Animal Health (ELAN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $23.54
    +0.99 (+4.37%)

    Market Cap: $11.26B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    91%(29/32)
    Avg Surprise
    +26.58%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.21
    Range$0.19 - $0.24
    12 analysts
    EPS Revisions
    2
    0
    7d
    9
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.19+5.6%
    60d ago$0.19+5.6%
    30d ago$0.21-0.3%
    7d ago$0.21-0.3%
    Current$0.21
    Revenue Consensus
    $1.2B
    Range$1.2B - $1.2B
    10 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.32
    Range$0.28 - $0.40
    14 analysts
    Revenue Consensus
    $1.3B
    Range$1.3B - $1.3B
    12 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.32---
    Sep 26EST
    		-$0.21---
    Jun 26
    Reported Aug 5
    		$0.34$0.27+25.93%Beat+30.8%
    Mar 26
    Reported May 6
    		$0.40$0.34+17.65%Beat+8.1%
    Dec 25
    Reported Feb 24
    		$0.13$0.11+14.54%Beat-7.1%
    Sep 25
    Reported Nov 5
    		$0.19$0.13+46.15%Beat+46.2%
    Jun 25
    Reported Aug 7
    		$0.26$0.20+30.00%Beat-13.3%
    Mar 25
    Reported May 7
    		$0.37$0.30+23.33%Beat+8.8%
    Dec 24
    Reported Feb 25
    		$0.14$0.15-5.79%Miss+75.0%
    Sep 24
    Reported Nov 7
    		$0.13$0.12+8.33%Beat-27.8%
    Jun 24
    Reported Aug 8
    		$0.30$0.24+25.00%Beat+66.7%
    Mar 24
    Reported May 8
    		$0.34$0.27+25.93%Beat-24.4%
    Dec 23
    Reported Feb 26
    		$0.08$0.11-27.27%Miss-57.9%
    Sep 23
    Reported Nov 7
    		$0.18$0.12+50.00%Beat-10.0%
    Jun 23
    Reported Aug 7
    		$0.18$0.05+260.00%Beat-50.0%
    Mar 23
    Reported May 9
    		$0.45$0.29+55.17%Beat+25.0%
    Dec 22
    Reported Feb 21
    		$0.19$0.13+46.15%Beat-9.5%
    Sep 22
    Reported Nov 8
    		$0.20$0.16+25.00%Beat+5.3%
    Jun 22
    Reported Aug 8
    		$0.36$0.25+44.00%Beat+28.6%
    Mar 22
    Reported May 9
    		$0.36$0.35+2.86%Beat-2.7%
    Dec 21
    Reported Feb 24
    		$0.21$0.17+23.53%Beat+75.0%
    Sep 21
    Reported Nov 5
    		$0.19$0.17+11.76%Beat+46.2%
    Jun 21
    Reported Aug 9
    		$0.28$0.26+7.69%Beat+211.1%
    Mar 21
    Reported May 7
    		$0.37$0.23+60.87%Beat+184.6%
    Dec 20
    Reported Feb 24
    		$0.12$0.09+33.33%Beat-47.8%
    Sep 20
    Reported Nov 6
    		$0.13$0.12+8.33%Beat-56.7%
    Jun 20
    Reported Jul 30
    		$0.09$0.07+28.57%Beat-67.9%
    Mar 20
    Reported May 7
    		$0.13$0.24-45.83%Miss-48.0%
    Dec 19
    Reported Feb 19
    		$0.23$0.23+0.00%Beat-20.7%
    Sep 19
    Reported Nov 6
    		$0.30$0.26+15.38%Beat+3.4%
    Jun 19
    Reported Aug 13
    		$0.28$0.26+7.69%Beat+128.9%
    Mar 19
    Reported May 9
    		$0.25$0.23+8.70%Beat-
    Dec 18
    Reported Feb 6
    		$0.29$0.27+7.41%Beat-
    Sep 18
    Reported Nov 6
    		$0.29$0.25+16.00%Beat-
    Jun 18
    Reported Sep 21
    		$-0.97$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio22.20EV/EBITDA19.54x
    Price/FCF31.02xFCF Yield3.22%
    Profitability
    Profit Margin-3.96%Operating Margin8.63%
    ROE-2.98%ROIC0.78%
    Financial Health
    Debt/Equity0.59xInterest Coverage0.33x
    Current Ratio2.05xQuick Ratio1.10x
    Trading Statistics
    Beta1.71Avg Volume5.46M
    52-Week High$27.9852-Week Low$19.40

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$22.60
    SMA 20$22.51
    SMA 50$23.18
    SMA 200$23.82
    EMA 10$22.70
    EMA 20$22.73
    EMA 50$23.18
    EMA 200$22.81

    MACD

    Line: -0.14Signal: -0.29Hist: 0.15

    ADX

    ADX: 11.3+DI: 25.0-DI: 18.5

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down60.0
    PSAR$21.65

    Bollinger Bands

    Upper Band$23.20
    Lower Band$21.83
    %B Position609%(Upper)
    Band Width1.25

    RSI (14-Day)

    Neutral
    58.3

    Momentum Oscillators

    Stoch %K69.8
    Stoch %D62.9
    Williams %R-11.8
    ROC (10d)8.1%
    Momentum1.76
    CCI (20d)257.2
    MFI (14d)65.5

    Volatility Measures

    ATR (14d)$0.72(3.1%)
    StdDev (20d)0.34
    Hist Vol26.0%(Moderate)

    Volume Flow

    VWAP$23.33
    OBV59.5M
    AD Line28.1M
    CMF (20d)-0.027

    Volume Metrics

    Avg Vol (20d)5.4M
    Vol Ratio1.2x
    VWMA (20d)$22.51

    Pivot Points

    R3$23.55
    R2$23.23
    R1$22.89
    Pivot Point$22.58
    S1$22.24
    S2$21.92
    S3$21.58

    Advanced Oscillators

    TSI-7.04
    Ultimate Osc56.9
    KST-36.72

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.37B$1.37B$1.14B$1.14B$1.24B$1.19B$1.02B$1.03B$1.18B$1.21B$1.03B$1.07B
    Cost of Revenue$570.00M$586.00M$555.00M$530.00M$528.00M$509.00M$501.00M$492.00M$495.00M$515.00M$516.00M$487.00M
    Gross Profit$798.00M$785.00M$589.00M$607.00M$713.00M$684.00M$519.00M$538.00M$689.00M$690.00M$519.00M$581.00M
    Operating Expenses$683.00M$641.00M$791.00M$605.00M$629.00M$572.00M$533.00M$561.00M$656.00M$603.00M$597.00M$1.60B
    R&D$92.00M$97.00M$93.00M$89.00M$92.00M$94.00M$81.00M$87.00M$89.00M$87.00M$79.00M$86.00M
    SG&A$449.00M$381.00M$338.00M$351.00M$400.00M$341.00M$300.00M$323.00M$354.00M$337.00M$292.00M$313.00M
    Operating Income$115.00M$144.00M$-202,000,000$2.00M$84.00M$112.00M$-14,000,000$-23,000,000$33.00M$87.00M$-78,000,000$-1,016,000,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$59.00M$57.00M$80.00M$52.00M$48.00M$40.00M$46.00M$58.00M$65.00M$66.00M$67.00M$72.00M
    Income Before Tax$56.00M$87.00M$-259,000,000$-50,000,000$25.00M$60.00M$-51,000,000$559.00M$-32,000,000$12.00M$-127,000,000$-1,097,000,000
    Income Tax Expense$2.00M$30.00M$17.00M$-16,000,000$14.00M$-7,000,000$-43,000,000$195.00M$18.00M$-20,000,000$14.00M$-1,000,000
    Net Income$54.00M$57.00M$-276,000,000$-34,000,000$11.00M$67.00M$-8,000,000$364.00M$-50,000,000$32.00M$-141,000,000$-1,096,000,000
    EBITDA$286.00M$316.00M$-5,000,000$178.00M$242.00M$261.00M$150.00M$787.00M$195.00M$244.00M$93.00M$-852,000,000
    EBIT$115.00M$144.00M$-179,000,000$2.00M$73.00M$100.00M$-14,000,000$617.00M$33.00M$78.00M$-78,000,000$-1,025,000,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ELAN

    News

    Officer Timothy J. Bettington proposes selling 4,350 shares of Elanco Animal Health (ELAN).

    Timothy J. Bettington, an officer at Elanco Animal Health Inc. (ELAN), has proposed selling 4,350 common shares valued at approximately $100,050. The shares are restricted stock units acquired on April 3, 2024...

    Stock Titan•10/15/26•Neutral

    More Than 2 Million Dogs Reach for Zen: Elanco Helps Veterinarians and Pet Owners Navigate Extended Allergy Season With Zenrelia™ (Ilunocitinib Tablets)

    Elanco's Zenrelia (ilunocitinib tablets) has treated over 2 million dogs worldwide for skin allergies, as a new report indicates a longer allergy season due to climate change. The once-daily oral JAK inhibitor helps...

    CSRwire•10/14/26•Bullish

    Q2 Earnings Outperformers: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Stocks

    This article reviews the Q2 earnings performance of pharmaceutical stocks, highlighting Elanco (NYSE:ELAN) as an outperformer with significant revenue and EPS beats. It also examines Bristol-Myers Squibb (NYSE:BMY)...

    Yahoo Finance•10/14/26•Somewhat-Bullish

    Form 4 Elanco Animal Health For: 11 October By Investing.com

    This article briefly announces the filing of Form 4 for Elanco Animal Health on October 11, 2026. Form 4 is a U.S. Securities and Exchange Commission filing used to disclose changes in beneficial ownership of a company's...

    Investing.com Canada•10/11/26•Neutral

    43 Years. Run Your Race.

    This article features a conversation with Donnie King, CEO of Tyson Foods, as he prepares to retire after a 43-year career. The discussion focuses on the structural shift in protein demand...

    CSRwire•10/9/26•Bullish

    ELAN Valuation and Fair Value

    P/E
    22.2x
    Forward P/E
    17.4x
    EV/EBITDA
    19.5x
    P/FCF
    31.0x
    PEG
    4.0x
    P/B
    1.8x
    See GNG's fair value

    ELAN Profitability: Margins, ROIC and FCF

    Gross margin
    55.4%
    Operating margin
    8.6%
    Net margin
    -4.0%
    ROIC
    0.8%
    ROE
    -3.0%
    FCF margin
    7.5%
    FCF yield
    3.2%

    ELAN Competitors

    CompanyTicker
    Repligen CorporationRGEN
    Fresenius Medical Care CorporationFMS
    Bio-Techne CorpTECH
    Vaxcyte IncPCVX
    DaVita HealthCare Partners IncDVA
    Universal Health Services IncUHS
    Smith & Nephew SNATS IncSNN
    Molina Healthcare IncMOH

    Sector: Healthcare

    ELAN Analyst Ratings

    Consensus
    Buy
    Analysts
    16
    Strong Buy
    4
    Buy
    10
    Hold
    2
    Sell
    0
    Strong Sell
    0

    ELAN Bull Case vs Bear Case

    Bull case

    • ELAN beat EPS estimates in 87.5% of its last 8 reported quarters.
    • ELAN grew quarterly revenue 10.2% year over year.
    • 87.5% of ELAN's analyst ratings are Buy or Strong Buy.

    Bear case

    • ELAN has a -4.0% net profit margin.

    ELAN Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    20.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.21
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    9 up, 1 down

    Frequently Asked Questions About ELAN

    Does ELAN pay dividends?

    Elanco Animal Health (ELAN) does not currently pay a regular dividend.

    What is ELAN's P/E ratio?

    Elanco Animal Health has a price-to-earnings (P/E) ratio of 22.20.

    What is ELAN's market cap?

    Elanco Animal Health (ELAN) has a market capitalization of $11.26B with a current stock price of $23.54.

    Related stocks

    Sector: Healthcare

    All stocks starting with E

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In